CoChat

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner

Open access
Keeton, Roanne, Richardson, Simone I., Moyo-Gwete, Thandeka, Hermanus, Tandile, Tincho, Marius B., Benede, Ntombi, Manamela, Nelia P., Baguma, Richard, Makhado, Zanele, Ngomti, Amkele, Motlou, Thopisang, Mennen, Mathilda, Chinhoyi, Lionel, Skelem, Sango, Maboreke, Hazel, Doolabh, Deelan, Iranzadeh, Arash, Otter, Ashley D., Brooks, Tim, Noursadeghi, Mahdad, Moon, James C., Grifoni, Alba, Weiskopf, Daniela, Sette, Alessandro, Blackburn, Jonathan, Hsiao, Nei-Yuan, Williamson, Carolyn, Riou, Catherine, Goga, Ameena, Garrett, Nigel, Bekker, Linda-Gail, Gray, Glenda, Ntusi, Ntobeko A.B., Moore, Penny L., Burgers, Wendy A. · 2021 · Cell Host & Microbe
Cited by 111

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

The Johnson and Johnson Ad26.COV2.S single dose vaccine, designed as an emergency response to the pandemic, represents an attractive option for the scale-up of COVID-19 vaccination in resource-limited countries. We examined the effect of prior infection with ancestral (D614G) or Beta variants on Ad26.COV2.S immunogenicity approximately 28 days post-vaccination. We compared healthcare workers who were SARS-CoV-2 naive (n=20), to those infected during the first wave prior to the emergence of Beta (n=20), and those infected in the second wave (n=20), when Beta was the dominant variant. We demonstrate that a priming exposure from infection significantly increased the magnitude of spike binding antibodies, neutralizing antibodies and antibody-dependent cellular cytotoxicity activity (ADCC) against D614G, Beta and Delta variants. The magnitude of antibody boosting was similar in both waves, despite the longer time interval between wave 1 infection and vaccination (7 months), compared to wave 2 (2 months). ADCC and binding cross-reactivity was similar in both waves. However, neutralization cross-reactivity varied by wave, showing that the antibody repertoire was shaped by the spike sequence of the infecting variant. Robust CD4 and CD8 T cell responses to spike of similar or higher magnitude as those elicited by infection were induced after vaccination. In contrast to antibody responses, prior infection was not required for the generation of high magnitude T cell responses, and T cell recognition of the Beta variant was fully preserved. Therefore, Ad26.COV2.S vaccination following prior infection, even >6 months previously, may result in substantially enhanced protection against COVID-19, of particular relevance in settings of high SARS-CoV-2 seroprevalence. Furthermore, the dominant impact of the infecting variant on neutralization breadth after vaccination has important implications for the design of second-generation vaccines based on variants of concern.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chom.2021.10.003

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 111

Metadata

Authors
Keeton, R., Richardson, S. I., Moyo-Gwete, T., Hermanus, T., Tincho, M. B., Benede, N., Manamela, N. P., Baguma, R., Makhado, Z., Ngomti, A., Motlou, T., Mennen, M., Chinhoyi, L., Skelem, S., Maboreke, H., Doolabh, D., Iranzadeh, A., Otter, A. D., Brooks, T., Noursadeghi, M., Moon, J. C., Grifoni, A., Weiskopf, D., Sette, A., Blackburn, J., Hsiao, N.-Y., Williamson, C., Riou, C., Goga, A., Garrett, N., Bekker, L.-G., Gray, G., Ntusi, N. A. B., Moore, P. L., & Burgers, W. A.
Venue
Cell Host & Microbe
Publisher
Elsevier BV
Published
2021-11
Volume
29
Issue
11
Pages
1611-1619.e5
ISSN
1931-3128 (ISSN-L)
OpenAlex
W3207910965
Cited by
111
References
33
FWCI
7.70
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.